ARTICLE | Politics, Policy & Law
As Congress considers Biosecure, report says WuXi companies low-risk
Rhodium Group report suggests Congress focus on economic rather than military threats from China biotech
November 19, 2024 11:14 PM UTC
A report from an influential consulting company challenges the focus of the Biosecure Act by suggesting that lawmakers are targeting low-risk Chinese biotech companies and overlooking higher-priority threats posed by companies with close ties to the Chinese government.
Two of the companies that would be subject to sanctions if the Biosecure Act (H.R. 8333) is enacted in its current form, WuXi AppTec Co. Ltd. (Shanghai:603259; HKEX:2359) and WuXi Biologics Inc. (HKEX:2269), pose low risks, according to the Rhodium Group report “Chinese Biotech Companies: A Fundamental Risk Scorecard.”...